Literature DB >> 6542261

Filaricidal effects of cyclosporin-A against Dipetalonema viteae in Mastomys natalensis.

D Bout, A Haque, A Capron.   

Abstract

Outbred male Mastomys natalensis were injected subcutaneously with 100 infective larvae of Dipetalonema viteae obtained from Ornithodorus tartakovskyi. Groups of five animals were treated with 30 mg/kg of the immunosuppressive drug Cyclosporin-A daily for five days (experimental) or Miglyol 812 (control). One group served as untreated controls. Contrary to expectations, 60% of the animals were completely protected against D. viteae and the remainder were partially protected. The mechanism remains unknown.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6542261     DOI: 10.1016/0035-9203(84)90236-0

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  5 in total

Review 1.  Dysregulation of strongyloidiasis: a new hypothesis.

Authors:  R M Genta
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

2.  Antischistosomal effect of cyclosporin A: cure and prevention of mouse and rat schistosomiasis mansoni.

Authors:  D Bout; D Deslèe; A Capron
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

3.  Cyclosporin A enhances elimination of intracellular L. major parasites by murine macrophages.

Authors:  C Bogdan; H Streck; M Röllinghoff; W Solbach
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

4.  Cyclosporin A inhibits the growth of Cryptococcus neoformans in a murine model.

Authors:  C H Mody; G B Toews; M F Lipscomb
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

5.  Dosage, timing, and route of administration of cyclosporin A and nonimmunosuppressive derivatives of dihydrocyclosporin A and cyclosporin C against Schistosoma mansoni in vivo and in vitro.

Authors:  L H Chappell; A W Thomson; G C Barker; S W Smith
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.